208 related articles for article (PubMed ID: 31244315)
1. Low Expression of MicroRNA335-5p Is Associated with Malignant Behavior of Gallbladder Cancer: A Clinicopathological Study.
Fatima N; Srivastava AN; Nigam J; Raza ST; Rizvi S; Siddiqui Z; Kumar V
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1895-1900. PubMed ID: 31244315
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
[TBL] [Abstract][Full Text] [Related]
3. Identification of miR-146b-5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma.
Lv YP; Shi W; Liu HX; Kong XJ; Dai DL
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):518-522. PubMed ID: 28239818
[TBL] [Abstract][Full Text] [Related]
4. High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma.
Lu K; Feng F; Yang Y; Liu K; Duan J; Liu H; Yang J; Wu M; Liu C; Chang Y
J Gastroenterol; 2020 Jan; 55(1):51-66. PubMed ID: 31562534
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
Zhou N; Cheng W; Peng C; Liu Y; Jiang B
Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB
Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA aberrations: An emerging field for gallbladder cancer management.
Chandra V; Kim JJ; Mittal B; Rai R
World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
[TBL] [Abstract][Full Text] [Related]
8. Identification of microRNAs associated with the survival of patients with gallbladder carcinoma.
Wang J; Jin Y; Li S; Song Q; Tang P
J Int Med Res; 2020 May; 48(5):300060520918061. PubMed ID: 32406793
[TBL] [Abstract][Full Text] [Related]
9. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer.
He M; Zhan M; Chen W; Xu S; Long M; Shen H; Shi Y; Liu Q; Mohan M; Wang J
Cell Physiol Biochem; 2017; 42(5):2078-2092. PubMed ID: 28803245
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA signatures in total peripheral blood of gallbladder cancer patients.
Li G; Pu Y
Tumour Biol; 2015 Sep; 36(9):6985-90. PubMed ID: 25861754
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7.
Ye YY; Mei JW; Xiang SS; Li HF; Ma Q; Song XL; Wang Z; Zhang YC; Liu YC; Jin YP; Hu YP; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu YB
Cell Death Dis; 2018 Mar; 9(3):410. PubMed ID: 29540696
[TBL] [Abstract][Full Text] [Related]
12. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p.
Goeppert B; Truckenmueller F; Ori A; Fritz V; Albrecht T; Fraas A; Scherer D; Silos RG; Sticht C; Gretz N; Mehrabi A; Bewerunge-Hudler M; Pusch S; Bermejo JL; Dietrich P; Schirmacher P; Renner M; Roessler S
Sci Rep; 2019 Mar; 9(1):4796. PubMed ID: 30886199
[TBL] [Abstract][Full Text] [Related]
13. MiR-20a triggers metastasis of gallbladder carcinoma.
Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
[TBL] [Abstract][Full Text] [Related]
14. Identification of invasion-metastasis associated MiRNAs in gallbladder cancer by bioinformatics and experimental validation.
Cao J; Shao H; Hu J; Jin R; Feng A; Zhang B; Li S; Chen T; Jeungpanich S; Topatana W; Tian Y; Lu Z; Cai X; Chen M
J Transl Med; 2022 Apr; 20(1):188. PubMed ID: 35484565
[TBL] [Abstract][Full Text] [Related]
15. High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma.
Kono H; Nakamura M; Ohtsuka T; Nagayoshi Y; Mori Y; Takahata S; Aishima S; Tanaka M
Oncol Rep; 2013 Jul; 30(1):17-24. PubMed ID: 23660842
[TBL] [Abstract][Full Text] [Related]
16. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
[TBL] [Abstract][Full Text] [Related]
17. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression.
Zhang X; Zhang L; Chen M; Liu D
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):315-324. PubMed ID: 31858815
[TBL] [Abstract][Full Text] [Related]
18. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2.
Li XL; Li SZ; Wu CX; Xing XH
Kaohsiung J Med Sci; 2021 Apr; 37(4):294-304. PubMed ID: 33236530
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor.
Cai J; Xu L; Cai Z; Wang J; Zhou B; Hu H
Mol Med Rep; 2015 Jul; 12(1):1549-55. PubMed ID: 25760482
[TBL] [Abstract][Full Text] [Related]
20. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z
Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
